StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.05 (-5.21%)

Close on Nov 17, 2026Market cap $3.99MP/E –Yield –

Sonoma Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Sonoma Pharmaceuticals's price to sales ratio was 0.3× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.1× to 0.9×, with a median of 0.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.1
2025Dec 31, 20250.4×+0.1
2024Dec 31, 20240.3×+0.2
2023Dec 29, 20230.1×−0.2
2022Dec 30, 20220.3×−0.7
2021Dec 31, 20210.9×+0.2
2020Dec 31, 20200.7×+0.4
2019Dec 31, 20190.3×+0.0
2018Dec 31, 20180.3×−1.3
2017Dec 29, 20171.5×−0.5
2016Dec 30, 20162.0×+0.8
2015Dec 31, 20151.3×+0.3
2014Dec 31, 20141.0×−0.7
2013Dec 31, 20131.6×+0.3
2012Dec 31, 20121.4×−1.1
2011Dec 30, 20112.4×–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?